Delivery Order SPE2DB25D7067-SPE2DB26FSUFF
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for Fluticasone Propionate HFA 44 micrograms in a 10.6-gram inhaler, with a contract ceiling value of $1,741.73 and an ultimate completion date of June 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a small-value...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 44 mcg inhalers (10.6 grams) valued at $1,225.92. This non-competitive delivery order was awarded on October 30, 2025, with an ultimate completion date of October 31, 2025, and reflects a firm fixed-price contract type. The pharmaceutical product will be performed and delivered from AmerisourceBergen's Conshohocken, Pennsylvania facility, the company's corporate headquarters....
- The Defense Logistics Agency awarded a delivery order valued at $6,795.88 to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Fluticasone Propionate HFA 220 micrograms in 12-gram inhalers. The contract is a firm fixed-price delivery order with a completion deadline of November 7, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Fluticasone Propionate HFA 44 micrograms in 10.6-gram inhalers, with a ceiling value of $4,633.71. This competitive award, utilizing firm fixed pricing, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.9 billion through December 2026. The order is set to be completed by...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Fluticasone Propionate HFA 220 micrograms in 12-gram inhalers, valued at $11,581.53. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation and an ultimate completion date of October 24, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for Fluticasone Propionate HFA 44 micrograms in a 10.6-gram inhaler, with a ceiling value of $1,288.20 and an ultimate completion date of August 18, 2025. This competitive, firm fixed-price delivery order was issued without a set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Fluticasone Propionate HFA 110 MCG inhalers (12 GM units) with a ceiling value of $1,561.88. This competitively awarded, firm fixed-price delivery order is set to be completed by July 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under a larger federal contract vehicle,...
- The Defense Logistics Agency awarded a delivery order valued at $2,108.90 to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Fluticasone Propionate HFA 110 mcg inhalers (12 grams), with an ultimate completion date of July 15, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction under AmerisourceBergen's existing contract vehicle with DLA. The product will be delivered to the company's location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Fluticasone Propionate HFA 220 micrograms in a 12-gram inhaler. This competitively awarded, non-set-aside contract carries a ceiling value of $3,753.01 and is structured as a firm fixed-price delivery order with an ultimate completion date of August 14, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Fluticasone Propionate HFA 110 mcg inhalers (12 grams), with a contract ceiling value of $4,217.23. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract involves...
- SPE2DB25D7067Indefinite Delivery Contract
- SPE2DB25D7067-SPE2DB26FSUFFDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Fluticasone Propionate HFA 44 micrograms in 10.6-gram inhalers, with a contract ceiling value of $5,882.40. This competitive, non-set-aside delivery order represents a firm fixed price procurement with an ultimate completion date of November 7, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The IDC serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply an extensive range of pharmaceutical products and medical supplies—including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities—to support military healthcare programs worldwide. Through this contract structure, the company provides critical pharmaceutical support to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.9k | 11/6/25 |